Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Inspire Medical Systems, Inc.INSP · Entity 1186 | See Remarks | August 31, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Inspire Medical Systems, Inc.
Report date August 31, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 25,335 |
Reported balance
After 2026-08-31 transaction · row 1
1 source rowRow 1 · 2026-08-31 · Grant · Acquired 6,350 · Balance 25,335 F1: Represents an award of restricted stock units ("RSUs"), which vests in three equal annual installments commencing on August 31, 2027. Each RSU represents a contingent right to receive one share of the Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units ("RSUs"), which vests in three equal annual installments commencing on August 31, 2027. Each RSU represents a contingent right to receive one share of the Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 31, 2026 Filed Sep 3, 2026 00:29 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 6,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-104850 · tm2624722-1_4seq1.xml · nonDerivative · entry 1 Kelly Jason P · CIK 0002057473 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,335 F1 · shares: Represents an award of restricted stock units ("RSUs"), which vests in three equal annual installments commencing on August 31, 2027. Each RSU represents a contingent right to receive one share of the Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| August 07, 2026 Filed Aug 11, 2026 23:13 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | SaleCommon Stock | 963 | $59.55 | $57,346.65 |
DisclosureSEC source: 0001104659-26-094238 · tm2622926-1_4seq1.xml · nonDerivative · entry 1 Kelly Jason P · CIK 0002057473 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,985 Read SEC document |
| February 20, 2026 Filed Feb 25, 2026 00:06 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 15,958 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-019286 · tm267181-5_4seq1.xml · nonDerivative · entry 1 Kelly Jason P · CIK 0002057473 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,948 F1 · shares: Represents an award of restricted stock units ("RSUs"), which vests in three equal annual installments commencing on February 20, 2027. Each RSU represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant dates. Read SEC document |
| February 13, 2026 Filed Feb 18, 2026 21:06 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | Tax withholdingCommon Stock | 551 | $59.76 | $32,927.76 |
DisclosureSEC source: 0001104659-26-017045 · tm266746-3_4seq1.xml · nonDerivative · entry 1 Kelly Jason P · CIK 0002057473 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,990 F1 · shares: Reflects shares of common stock that were withheld by the Issuer to satisfy taxes incident to vesting of a restricted stock unit award. Read SEC document |
| February 13, 2025 Filed Feb 25, 2025 01:03 UTC | Inspire Medical Systems, Inc. INSP · Entity 1186 | GrantCommon Stock | 4,541 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-016633 · tm257494-2_4seq1.xml · nonDerivative · entry 1 Kelly Jason P · CIK 0002057473 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,541 F1 · shares: Represents an award of restricted stock units, which vests in three equal annual installments commencing on February 13, 2026. Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.